Section 431A.900 – Civil penalty for violation of ORS 431A.855 to 431A.900.
(1) In addition to any other penalty provided by law, the Attorney General may impose a civil penalty not to exceed $10,000 for each violation of ORS 431A.860, 431A.865 or 431A.870. Each improper release of information from the prescription monitoring program in violation of ORS 431A.865 is a separate violation. (2) Civil penalties under this […]
Section 431A.867 – Agreement for use of program information.
(1) The Oregon Health Authority may require a person requesting prescription monitoring program information under ORS 431A.865 (3)(b) to enter into a data use agreement under which the person: (a) Describes the proposed use for the information; (b) Agrees to any terms and conditions imposed on transferring the information; (c) Agrees to any limitations imposed […]
Section 431A.869 – Sharing and use of program information with other states.
The Oregon Health Authority may enter into agreements governing the sharing and use of information described in ORS 431A.860 (1) with the authorities of other states that administer prescription monitoring programs. An agreement entered into under this section must adhere to the disclosure limitations listed under ORS 431A.865 (3). An agreement entered into under this […]
Section 431A.870 – Duty of pharmacist to fill prescription.
A pharmacist may not refuse to fill a valid prescription solely because the pharmacist cannot receive patient information from the prescription monitoring program established under ORS 431A.855 at the time the patient requests that the prescription be filled. [Formerly 431.968]
Section 431A.875 – Reports to health professional regulatory boards.
If a practitioner or pharmacist authorized to obtain prescription information from the electronic system established under ORS 431A.855 discloses or uses information obtained from the electronic system in violation of ORS 431A.865, the Oregon Health Authority shall report the individual to the appropriate health professional regulatory board. [Formerly 431.970; 2017 c.683 §15]
Section 431A.877 – Duty to register; rules.
(1) In order to ensure the development, administration and evaluation of best practices for prescribing opioids and opiates, a practitioner shall register with the electronic system established under ORS 431A.855. (2) The Oregon Health Authority may adopt rules to administer this section. [2018 c.45 §7]
Section 431A.880 – Licensing information; fees; rules.
(1) As used in this section, “board” means: (a) The Oregon Medical Board; (b) The Oregon Board of Dentistry; (c) The Oregon Board of Naturopathic Medicine; (d) The Oregon State Board of Nursing; (e) The Oregon Board of Optometry; and (f) The State Board of Pharmacy. (2)(a) At the time of issuing or renewing a […]
Section 431A.890 – Prescription Monitoring Program Advisory Commission; purposes; members.
(1) The Prescription Monitoring Program Advisory Commission is created for the purposes of: (a) Studying issues related to the prescription monitoring program established under ORS 431A.855; (b) Reviewing the program’s annual report and making recommendations to the Oregon Health Authority regarding the operation of the program; and (c) Developing criteria used to evaluate program data. […]
Section 431A.895 – Term; meetings; rules; quorum; expenses.
(1) The term of office of each member of the Prescription Monitoring Program Advisory Commission is four years, but a member serves at the pleasure of the Oregon Health Authority. Before the expiration of the term of a member, the authority shall appoint a successor whose term begins on July 1 next following. A member […]
Section 431A.896 – Prescription Monitoring Program Prescribing Practices Review Subcommittee.
(1) The Prescription Monitoring Program Prescribing Practices Review Subcommittee is established as a subcommittee of the Prescription Monitoring Program Advisory Commission created under ORS 431A.890, for the purpose of advising the Oregon Health Authority and the commission on interpreting prescription information, understanding the clinical aspects of prescribing practices and evaluating prescribing practices. (2)(a) The authority […]